Overall, these data indicate that the ability of the CD9/CD81 complex to promote α3β1 integrin-dependent motility is not restricted to the MDA-MB-231 breast cancer model, although, unlike MDA-MB-231 cells, A431 cells also exhibit an ongoing requirement for CD151 for rapid migration on LM-332 [30]. The gene discussed is CD9; the disease is breast cancer.